Trial site
Northern California Retina Vitreous Associates
- 5running trials
- 7closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration9 trials
- Diabetic eye disease2 trials
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Completed6 trials
- Active, not recruiting4 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche3 trials
- 4D Molecular Therapeutics2 trials
- Genentech, Inc.2 trials
- Apellis Pharmaceuticals, Inc.1 trial
- Aviceda Therapeutics, Inc.1 trial
- and 3 more
Running trials
Recruiting
Recruiting
(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Active, not recruiting
An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration1 recruiting
Closed trials
Completed
Completed
Completed
Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study
Completed
Completed
Completed
Terminated
HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Site data: ClinicalTrials.govUpdated 15 Nov 2026